Come up with a name for your new list and we'll add to it:
CELLective Dx Corporation raised a round of funding on October 23, 2006. Investors include
Mohr Davidow Ventures.
CELLective Dx is an early-stage company developing a new generation of diagnostic tools for cancer based on analysis of CTCs directly from a patient's blood. Our novel proprietary technologies combine…